NGL Fine-Chem Limited (NSE:NGLFINE)
1,284.90
-0.70 (-0.05%)
May 22, 2025, 3:15 PM IST
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
Human and Veterinary Active Pharmaceutical Ingredients | 3.34B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Human and Veterinary Active Pharmaceutical Ingredients Growth | 21.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Allopathic Medicine | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Chemical Substances | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
Asia Pacific | 980.01M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia Pacific Growth | 5.67% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of the World | 797.74M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of the World Growth | 133.36% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
India | 792.74M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
India Growth | 31.46% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe | 704.59M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Growth | -12.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States | 62.03M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States Growth | 12.62% |
Log In |
Log In |
Log In |
Log In | Upgrade
|